Gellerup Dane D, Balgeman Alexis J, Nelson Chase W, Ericsen Adam J, Scarlotta Matthew, Hughes Austin L, O'Connor Shelby L
Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, USA.
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
J Virol. 2015 Oct 21;90(1):545-52. doi: 10.1128/JVI.02587-15. Print 2016 Jan 1.
Anti-HIV CD8 T cells included in therapeutic treatments will need to target epitopes that do not accumulate escape mutations. Identifying the epitopes that do not accumulate variants but retain immunogenicity depends on both host major histocompatibility complex (MHC) genetics and the likelihood for an epitope to tolerate variation. We previously found that immune escape during acute SIV infection is conditional; the accumulation of mutations in T cell epitopes is limited, and the rate of accumulation depends on the number of epitopes being targeted. We have now tested the hypothesis that conditional immune escape extends into chronic SIV infection and that epitopes with a preserved wild-type sequence have the potential to elicit epitope-specific CD8 T cells. We deep sequenced simian immunodeficiency virus (SIV) from Mauritian cynomolgus macaques (MCMs) that were homozygous and heterozygous for the M3 MHC haplotype and had been infected with SIV for about 1 year. When interrogating variation within individual epitopes restricted by M3 MHC alleles, we found three categories of epitopes, which we called categories A, B, and C. Category B epitopes readily accumulated variants in M3-homozygous MCMs, but this was less common in M3-heterozygous MCMs. We then determined that chronic CD8 T cells specific for these epitopes were more likely preserved in the M3-heterozygous MCMs than M3-homozygous MCMs. We provide evidence that epitopes known to escape from chronic CD8 T cell responses in animals that are homozygous for a set of MHC alleles are preserved and retain immunogenicity in a host that is heterozygous for the same MHC alleles.
Anti-HIV CD8 T cells that are part of therapeutic treatments will need to target epitopes that do not accumulate escape mutations. Defining these epitope sequences is a necessary precursor to designing approaches that enhance the functionality of CD8 T cells with the potential to control virus replication during chronic infection or after reactivation of latent virus. Using MHC-homozygous and -heterozygous Mauritian cynomolgus macaques, we have now obtained evidence that epitopes known to escape from chronic CD8 T cell responses in animals that are MHC homozygous are preserved and retain immunogenicity in a host that is heterozygous for the same MHC alleles. Importantly, our findings support the conditional immune escape hypothesis, such that the potential to present a greater number of CD8 T cell epitopes within a single animal can delay immune escape in targeted epitopes. As a result, certain epitope sequences can retain immunogenicity into chronic infection.
治疗性治疗中所包含的抗HIV CD8 T细胞需要靶向那些不会积累逃逸突变的表位。识别那些不会积累变异但仍保留免疫原性的表位,既取决于宿主主要组织相容性复合体(MHC)的遗传学特征,也取决于表位耐受变异的可能性。我们之前发现,急性SIV感染期间的免疫逃逸是有条件的;T细胞表位中的突变积累是有限的,且积累速率取决于被靶向的表位数量。我们现在检验了这样一个假设,即有条件的免疫逃逸会延伸至慢性SIV感染,并且具有保留野生型序列的表位有潜力引发表位特异性CD8 T细胞。我们对来自毛里求斯食蟹猴(MCM)的猿猴免疫缺陷病毒(SIV)进行了深度测序,这些食蟹猴对于M3 MHC单倍型是纯合子和杂合子,并且已感染SIV约1年。当探究受M3 MHC等位基因限制的各个表位内的变异时,我们发现了三类表位,我们将其称为A、B和C类。B类表位在M3纯合子MCM中很容易积累变异,但在M3杂合子MCM中这种情况较少见。然后我们确定,针对这些表位的慢性CD8 T细胞在M3杂合子MCM中比在M3纯合子MCM中更有可能得以保留。我们提供的证据表明,在一组MHC等位基因纯合的动物中已知会从慢性CD8 T细胞应答中逃逸的表位,在对于相同MHC等位基因是杂合子的宿主中得以保留并保留免疫原性。
作为治疗性治疗一部分的抗HIV CD8 T细胞需要靶向那些不会积累逃逸突变的表位。确定这些表位序列是设计增强CD8 T细胞功能方法的必要前提,这些方法有可能在慢性感染期间或潜伏病毒重新激活后控制病毒复制。利用MHC纯合子和杂合子毛里求斯食蟹猴,我们现在获得的证据表明,在MHC纯合的动物中已知会从慢性CD8 T细胞应答中逃逸的表位,在对于相同MHC等位基因是杂合子的宿主中得以保留并保留免疫原性。重要的是,我们的发现支持有条件免疫逃逸假说,即单个动物内呈现更多CD8 T细胞表位的潜力可以延迟靶向表位中的免疫逃逸。因此,某些表位序列在慢性感染中可以保留免疫原性。